AbbVie to Host Fourth-Quarter and Full-Year 2020 Earnings Conference Call
Tue, January 12, 2021, 8:00 AM EST

AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2020 financial results on Wednesday, February 3, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-and-full-year-2020-earnings-conference-call-301205553.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MCIG Reports Positive Operating Cash Flow

mCig(R), Inc. Reports Positive Operating Cash Flow 240% Increase in Quarterly Revenue…

$GBLX Announces Commercialization Initiative and Financing

Growblox Announces Commercialization Initiative and Financing Growblox Sciences, Inc. (GBLX), a biopharmaceutical…

$TAUG Completes $105,500 USD Equity Private Placement

Tauriga Sciences Inc. Completes $105,500 USD Equity Private Placement With Accredited Individual…

$UMBBF Medical Cannabis Application is Progressing and is Currently in the Enhanced Screening Stage

Medical Cannabis Application is Progressing and is Currently in the Enhanced Screening…